Heres how its different from previous meds: Retatrutide is a triple agonist, meaning it targets three different hormone receptors, rather than one (like Ozempic) or two (like Mounjaro or Zepbound)
The regulatory team, manufacturing infrastructure, and commercial playbook are already in place
Furthermore, acupoint stimulation affects energy metabolism and hormonal functions by decreasing levels of leptin, growth hormone releasing peptide, insulin, and miR-32-3p, while upregulating group IV phospholipases A2 and stimulating skeletal muscle Sirtuin 1 (SIRT1)/peroxisome proliferator-activated receptor coactivator 1
Semaglutide belongs to a class of medicines known as glucagon-like peptide-1 (GLP-1) receptor agonists, which are commonly used to help people manage type 2 diabetes and, at higher doses support weight management